Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pethidine + midazolam versus fentanyl + midazolam for sedation during diagnostic bronchoscopy
IRCT20260708070102N1Phase 2Recruiting
- Sponsor
- Iran University of Medical Sciences
- Start
- Aug 2026
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of pethidine, midazolam and fentanyl in None (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoints: Patient satisfaction and tolerance, Level of sedation and 6 more. Started Aug 2026; status: recruiting.
02
Drugs
pethidinemidazolamfentanyl
Beyond the preview
Go deeper on IRCT20260708070102N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260708070102N1.